Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

silodosin

Known as: 1-(3-hydroxypropyl)-5-(2-(2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethylamino)propyl)indoline-7-carboxamide 
An orally available, alpha-1 adrenoreceptor (alpha-1a) selective antagonist that can be used to relieve symptoms of benign prostate hyperplasia (BPH… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
BACKGROUND Using a selective α-blocker for medical expulsive therapy (MET) is a cost-effective treatment approach widely used for… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Highly Cited
2015
Highly Cited
2015
OBJECTIVE To evaluate the role of 2 different α-1 blockers and 1 phosphodiesterase-5 inhibitor as medical expulsive therapy for… Expand
  • figure 1
  • table 1
  • table 2
Highly Cited
2013
Highly Cited
2013
PURPOSE We evaluated the efficacy and safety of silodosin for treatment of benign prostatic hyperplasia symptoms in 2 randomized… Expand
Highly Cited
2011
Highly Cited
2011
PURPOSE We evaluated the efficacy and safety of 2 doses of silodosin vs placebo in men with moderate to severe abacterial chronic… Expand
Highly Cited
2011
Highly Cited
2011
Objectives:  The aim of the present study was to explore the effects of three different types of alpha‐1 adrenoceptor blockers… Expand
Highly Cited
2010
Highly Cited
2010
OBJECTIVES To provide clinical evidence that ejaculation disorder caused by selective alpha(1A)-blockers may be associated with… Expand
Highly Cited
2010
Highly Cited
2010
To investigate urodynamically the effects of silodosin, a new α1A‐adrenoceptor‐selective antagonist, in the treatment of benign… Expand
Highly Cited
2009
Highly Cited
2009
PURPOSE We evaluated the efficacy and safety of silodosin for treatment of benign prostatic hyperplasia symptoms in 2 randomized… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Highly Cited
2009
Highly Cited
2009
OBJECTIVES To evaluate long-term safety of the highly selective alpha(1A)-adrenoceptor antagonist silodosin in men with signs and… Expand
Highly Cited
2006
Highly Cited
2006
This section contains papers from Japan, Austria, the UK, and joint papers from France, Denmark, Switzerland, Australia and the… Expand